Search Results - "Bhola, NE"

Abstract PD2-06: Inhibition of 3-phosphoinositide dependent protein kinase 1 (PDK1) synergizes with CDK4/6 inhibitors against ER-positive breast cancer by Jansen, VM, Bhola, NE, Bauer, JA, Formisano, L, Moore, P, Koch, J, Arteaga, CL

“…Abstract Background: Dysregulation in cell cycle checkpoints is common in cancer. Small molecule inhibitors that target the CDK4/6/cyclinD1 pathway of the cell…”
Get full text

Abstract S3-03: Nuclear FGFR1 interaction with estrogen receptor (ER) α is associated with resistance to endocrine therapy in ER+/FGFR1-amplified breast cancer by Formisano, L, Young, CD, Bhola, NE, Bulen, B, Estrada, VM, Wagle, N, Van Allen, E, Red Brewer, ML, Jansen, VM, Guerrero, AL, Giltnane, JM, Strcker, T, Arteaga, CL

“…Abstract Background: Estrogen receptor (ER)-positive breast cancers (BC) initially respond to antiestrogens but eventually become hormone-independent and…”
Get full text

PD08-03: Inhibition of MEK/ERK- and JNK-Dependent Expression of Interleukin-6 and Interleukin-8 Targets Basal-Like Breast Cancer Stem Cells by Balko, JM, Cook, RS, Kuba, MG, Miller, TW, Bhola, NE, Sanders, ME, Meszoely, IM, Dowsett, M, Gomez, H, Arteaga, CL

“…Abstract Background: Neoadjuvant chemotherapy (NAC) induces a pathological complete response in approximately 30% of triple-negative or basal-like breast…”
Get full text